These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 29786643)
1. Controlled-Deactivation CB1 Receptor Ligands as a Novel Strategy to Lower Intraocular Pressure. Miller S; Kulkarni S; Ciesielski A; Nikas SP; Mackie K; Makriyannis A; Straiker A Pharmaceuticals (Basel); 2018 May; 11(2):. PubMed ID: 29786643 [TBL] [Abstract][Full Text] [Related]
2. Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model. Miller S; Leishman E; Hu SS; Elghouche A; Daily L; Murataeva N; Bradshaw H; Straiker A Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3287-96. PubMed ID: 27333182 [TBL] [Abstract][Full Text] [Related]
3. Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Regulate Intraocular Pressure. Miller S; Daily L; Leishman E; Bradshaw H; Straiker A Invest Ophthalmol Vis Sci; 2018 Dec; 59(15):5904-5911. PubMed ID: 30550613 [TBL] [Abstract][Full Text] [Related]
4. Endocannabinoid metabolism and transport as targets to regulate intraocular pressure. Miller S; Daily L; Dharla V; Gertsch J; Malamas MS; Ojima I; Kaczocha M; Ogasawara D; Straiker A Exp Eye Res; 2020 Dec; 201():108266. PubMed ID: 32979397 [TBL] [Abstract][Full Text] [Related]
5. Evidence that cannabinoid CB1 receptors regulate intraocular pressure via two opposing mechanisms. Miller S; Daily L; Ploss M; Greig I; Ross R; Rayana NP; Dai J; Sugali CK; Mao W; Straiker A Exp Eye Res; 2020 Nov; 200():108241. PubMed ID: 32941875 [TBL] [Abstract][Full Text] [Related]
6. The In Vivo Effects of the CB Cairns EA; Szczesniak AM; Straiker AJ; Kulkarni PM; Pertwee RG; Thakur GA; Baldridge WH; Kelly MEM J Ocul Pharmacol Ther; 2017 Oct; 33(8):582-590. PubMed ID: 28719234 [TBL] [Abstract][Full Text] [Related]
7. Comparison of the enzymatic stability and intraocular pressure effects of 2-arachidonylglycerol and noladin ether, a novel putative endocannabinoid. Laine K; Järvinen K; Mechoulam R; Breuer A; Järvinen T Invest Ophthalmol Vis Sci; 2002 Oct; 43(10):3216-22. PubMed ID: 12356827 [TBL] [Abstract][Full Text] [Related]
8. Type 1 cannabinoid receptor ligands display functional selectivity in a cell culture model of striatal medium spiny projection neurons. Laprairie RB; Bagher AM; Kelly ME; Dupré DJ; Denovan-Wright EM J Biol Chem; 2014 Sep; 289(36):24845-62. PubMed ID: 25037227 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of the endocannabinoid-regulating enzyme monoacylglycerol lipase elicits a CB Owens RA; Mustafa MA; Ignatowska-Jankowska BM; Damaj MI; Beardsley PM; Wiley JL; Niphakis MJ; Cravatt BF; Lichtman AH Neuropharmacology; 2017 Oct; 125():80-86. PubMed ID: 28673548 [TBL] [Abstract][Full Text] [Related]
10. The Endocannabinoid System Modulating Levels of Consciousness, Emotions and Likely Dream Contents. Murillo-Rodriguez E; Pastrana-Trejo JC; Salas-Crisóstomo M; de-la-Cruz M CNS Neurol Disord Drug Targets; 2017; 16(4):370-379. PubMed ID: 28240187 [TBL] [Abstract][Full Text] [Related]